Patients who take the diabetes drug metformin may be less likely to die over the course of 10 years than patients who take insulin secretagogues, a new study has found. The study of 107,806 diabetics found that patients who took secretagogues were 20 to 33 percent more likely to die over the course of the study than those who took the more commonly prescribed metformin.
Read moreMetformin (generic) or Glucophage (brand) has become a very popular therapeutic agent in multiple medical conditions. According to David... Read more »
The drug metformin is not recommended for people with kidney disease. For this reason, some people think that metformin causes kidney... Read more »
A recent report again reaffirms that metformin is the first medication to use when a patient with type 2 diabetes (T2D) needs help with... Read more »
When people with type 2 diabetes could take a pill instead of insulin to help us control our diabetes, smiles must have appeared on many... Read more »
I received an interesting question by e-mail recently, which brought up several good points to review. The author asked: "Can a patient... Read more »
This is a study to determine the effects of adding liraglutide to an existing treatment of rosiglitazone (Avandia) and metformin, and then to compare... Read more »
This is a study to compare the safety and effectiveness of a combination of prandial inhaled insulin and metformin with the inhaled insulin and a... Read more »
Metformin may lower diabetics' risk of pancreatic cancer by up to 60 percent, a new study suggests. Read more »
U.S. researchers say the diabetes drug Metformin is safe for patients with advanced heart failure. In a study of 401 diabetic patients with the... Read more »
The diabetes drug metformin has shown success in treating breast cancer when paired with common chemotherapy drugs, a mouse study suggests.... Read more »